Ladies and gentlemen, Good Day and Welcome to the Birlasoft Limited Q3 FY25 Results Conference Call. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the call, please signal an operator by pressing star, then zero on your touch-tone phone. I now hand the conference over to Mr. Abhinandan Singh, Head Investor Relations, Birlasoft. Thank you, and over to you, Mr. Singh.
Thank you and welcome, folks. By now, you'll have received our results. Those are also available on our website, www.birlasoft.com. Joining me on this call today are our CEO and MD, Mr. Angan Guha, and our CFO, Ms. Kamini Shah. We will begin the call today, as usual, with opening remarks from both Angan and Kamini, and then we'll follow that up with some time for your questions and responses to those. But before I hand over the floor to Angan, a quick reminder that anything that we say on this call and becomes our outlook for the future could be a forward-looking statement, and therefore that must be heard or read in conjunction with the disclaimer that appears in our third quarter FY25 investor update, which you would have received, and it is also uploaded on our website as well as filed with these conference agents.
With that, let me hand over the floor now to Mr. Angan Guha, our CEO and MD. Over to you, Angan.
Yeah, thank you. Thank you, Abhi. So good evening and good morning to everyone, wherever you are, and thank you for joining us today as we share some perspectives on our performance during the third quarter for the current fiscal year. I trust all of you have seen our results. Our performance during the quarter reflects a seasonally weak quarter with higher furloughs than last year, compounded by the fact that the demand environment has not materially changed. While there are some early signs of improvement in certain pockets, such as BFSI, those are relatively smaller contributors, as you know, to our overall business. So with that context, let me delve into our Q3 performance. On a year-on-year basis, our revenue grew at 1.5% in reported terms, and in constant currency terms, it has been flattish.
We've witnessed higher-than-usual furloughs this year, and in some cases, the furloughs are even extending into January, and that has resulted in a softer revenue performance. On the margin front, we have reported an EBITDA of 12%, which is nearly the same sequentially from the Q2 quarter. The fact that we've been able to deliver this margin performance, even after absorbing the impact of compensation hikes that became effective from the 1st of October 2024, demonstrates our commitment to and our ability to sustain over time improving our margin profile. Kamini will delve more into these details during her remarks. We've also seen significant improvement on our cash balance thanks to continued strong cash generation. As a result, our balance sheet remains very robust.
On the deals front, I'm pleased to note that the deals signings during the quarter saw a sharp increase, and we delivered $226 million worth of TCV signings. This by far has been the best quarter in terms of deals signings in the current fiscal. While a large part of this has come in from renewals, which is typical for the time of the year, we've also seen some net new deals. Looking at the conversations that we are currently having with our clients, and including one potential large deal and a new logo in Europe, we also expect a good TCV performance in Q4 as well. On the operations front, while we already enjoy a solid presence across multiple competencies, I wish to share more on the areas that we have been investing in.
Our investments are focused on bridging capability gaps and scaling existing capabilities that we believe are and will remain relevant in the marketplace. In terms of the bets that we are making in our tech capability roadmap, we are particularly concentrating our efforts in AI, GenAI, and AI-driven quality assurance services, data, and product and app engineering. While GenAI, with GenAI, you will recall that we had established our GenAI center of excellence early last year and then had built our own GenAI platform called Cogito to accelerate GenAI-based solutions. We continue to harness the power of AI and GenAI to transform our operations with new innovative in-house applications such as Beehive, which is a GenAI conversational bot, and Saarthi, a GenAI solution integrated with ServiceNow.
These initiatives are aimed at bringing about structural changes in our business, and that will amplify our competitive advantage, make us more resilient, and enable us to better capitalize as demand conditions continue to improve. Looking ahead, as I observed earlier in my comments, the demand environment has not changed much from what we have seen over the past few quarters. There have been some signs of pickup in financial services, along with green shoots emerging on the discretionary side of customer spend. But it is too early to conclude that demand conditions have indeed turned around comprehensively. Clients' budgets in most cases still indicate a hold-and-wait approach, particularly in verticals like Life Sciences, which, as you know and may have noticed, is likely to be more subjected to policy shifts in line with the priorities of the new administration in the U.S.
Additionally, we have seen some amount of project rundowns this quarter, which might have a near-term impact on revenues. However, needless to say, we are working with our clients to minimize all of it. Ongoing conversations with clients across verticals do give us a sense that demand should gradually pick up as we progress into the calendar year. It will, however, take a couple of quarters for that to start reflecting meaningfully in our deal inflows and eventually in our revenues. Our deal pipeline remains quite heavy, and we continue to invest in our capabilities that will enable the next phase of growth in our journey. At this point, I ask Kamini, our CFO, to share her perspectives on the quarter and the year-end review. Kamini, over to you.
Thank you, Angan. Good evening, everyone. Hope you're doing well. Thank you for joining us. Let me take you through the financial highlights for the third quarter of the current financial year. As you would have seen, we have reported a consolidated revenue of $160.8 million for the quarter, representing a constant currency degrowth of 0.1% year-on-year and 1.1% quarter-on-quarter. In rupee terms, quarter three revenues have been at INR 1,327 million, a sequential growth of 1.5% year-on-year, and a slight decline of 0.4% quarter-on-quarter. Performance during the quarter under review was led by BFSI verticals, which has grown 1.8% quarter-on-quarter, as Angan mentioned in his remarks. Our quarterly performance reflects higher-than-usual furloughs in a seasonally weak quarter, particularly in the life sciences and the manufacturing verticals. In some cases, the furloughs came in late into the quarter and are spilling over into early Q4 as well.
Among service lines, our digital and data business, that contributes about 57% of the overall revenues, grew by 2.4% quarter-on-quarter. The ERP business witnessed a sequential decline of about 5.7%, reflecting seasonal weaknesses. Moving on to the EBITDA performance, our EBITDA for the quarter was at $19.3 million versus $19.7 million in Q2. This translates to an EBITDA margin of about 12%. This is marginally lower than what we had reported in the last quarter. This is despite our organization-wide wage increase that came into effect from October onwards, indicating a three-month impact of the wage hike. Margin savings that have enabled us to largely offset the impact of wage hikes and furloughs include exchange rate benefits from a strong dollar and some operational savings. Our PAT stood at $13.8 million, which is 9.3% lower on quarter-on-quarter basis.
This is because we have recorded a lower quantum of other income during the quarter under review. Our other income was lower primarily because of favorable non-dollar currencies such as GBP, Euro, and others that have depreciated significantly against the U.S. dollar and the rupee. Let me briefly touch upon the key balance sheet items. Our cash and bank balances at the end of the third quarter stood at $240 million, up 8.2% quarter-on-quarter and at about 18.3% year-on-year. We have, over the past several quarters, demonstrated our ability to consistently generate strong cash flows. Our operating cash flow for Q3 was at about $29.9 million, which is about 155% of our EBITDA. This has been on the back of strong quarterly collections. Consequently, we are happy to say that our DSO stands at 53 days, which is among the best in our industry.
In conclusion, I would like to say that we continue to enjoy a robust balance sheet with healthy cash flows. We are remaining focused on investing in capabilities for the future growth as we enter into the last quarter of the current financial year. Thank you very much. Back to you, Abhi.
Thanks, Kamini. Thanks, Angan. Margaret, can you please start the Q&A session?
Sure. Thank you very much. We will now begin the question-and-answer session. Anyone who wishes to ask questions may press star and one on the touch-tone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking questions. Ladies and gentlemen, we will wait for a moment while the question queue assembles. To ask questions, please press star and one. First question is from Ravi Menon from Macquarie. Please go ahead.
Hi. Thank you for the opportunity. Again, so we've seen a bit of offshore shift this quarter, some bit of headwind, I guess, from that, a little bit of headwind from the past revenue going away as well. And you talked about a lot of furloughs. So can we think that some of this is a very temporary headwind? And you said that this continues in January. And have we seen that end, or should we think about a similar sort of impact from furloughs for this quarter as well?
Yeah. So, Ravi, thank you for that question. So, look, like I mentioned, and Kamini also alluded to the fact that, unlike the previous years, this year we have seen more furloughs than usual, and those furloughs have come in a little late in the quarter, which kind of drove a little bit of muted performance, and the furloughs came in even from verticals where we had not seen furloughs earlier. Now, so it's a one-off situation, but just to answer your question, Ravi, the furloughs are extending into January as well, and since January is already over, the furloughs we've already accounted for, so that will show a little softness in revenue in Q4 as well. But like I said, we will concentrate on executing the quarter and see how much we can mitigate from those furlough impacts and see how the quarter goes.
Our focus will clearly be on order booking. You saw a good order booking performance in Q3, and we would like to repeat the same order booking performance in Q4 as well.
I mean, sorry, heard you right. You were talking about large deal with the new logo. Is that correct?
Yeah. So we are in discussions, Ravi, with a new logo in Europe where we think we can close a reasonable size deal. I will not call it a large deal. It is a reasonable size deal given the size of our company. So from our company standpoint, it will be. But it will be a marquee deal. We are still talking about it. We are confident on that. And if that gets concluded, we are confident of repeating the same performance as Q3 and Q4 in terms of order booking.
Thank you. And you had talked when you started this journey with the software about adding at least one major logo to each of the verticals. Can you talk a bit about the progress there and how you would have the sales team evolve now that group is departing? What's the plan? How are you reorganizing the sales team?
Yeah. So, Ravi, two questions, and let me answer that. So, of course, our endeavor is always to add at least one logo per vertical. And the logo that we hopefully will add a new logo in the manufacturing space in Europe will drive us towards that goal. But quite frankly, have we added a large logo in other verticals? The answer is no. But we've added new relationships. We've actually added, I think, Kamini, about three or four new logos in the three verticals that we serve. Now, how much will the logo scale? Only time will tell. But the logo that we are talking about adding in Q4 will also come along with the deal. But the second question that you asked about Roop departing, yes, Roop has decided to take up an opportunity outside of Birlasoft, and we wish him well.
So for now, I'm stepping in to run the Americas business as an additional responsibility while we look for a solid replacement that we are working on, Ravi.
Thanks a lot, Angan. Best of luck.
Thank you.
Thank you. Next question is from Shradha from AMSEC. Please go ahead.
Yeah. Hi. Thanks for taking my question. So you spoke about some near-term rundown in some deals. So any clarity on that front would be helpful.
Yeah. So, Shradha, again, thank you for that question. So there are two headwinds that we're seeing in Q4. One is, of course, like I said, some amount of furloughs in healthcare are spilling into the month of January. Now, of course, our job as a management team will be to minimize that as much as possible. So that's one. In terms of project rundowns, we are seeing some amount of project rundowns, not very large, but a little bit of project rundowns in healthcare as well as in manufacturing. So we will watch this space. That, of course, is BAU because if we win some good deals and drive a good order booking, again, some of that could be mitigated. So we'll have to see how that goes. We are already in the month of February, so the furloughs are already accounted for.
The deal signings are in the offing. So we will see how that pans out, Shradha.
So these project rundowns are over and above the furlough impact that we've seen in the month of January. I mean, is it?
That is correct. That is correct. Yes.
So given this context, how should we look at revenue in 4Q for us? I mean, it would be a declined quarter, I'm assuming, given we are talking of two such significant headwinds.
So, Shradha, again, we don't give a guidance usually. Our job will be to execute for the quarter. I can only tell you that while there are going to be furloughs, right, and there are going to be some amount of rundowns, equally, we have won $226 million worth of deals. So part of it we will try and mitigate. Our job will obviously be to mitigate as much as possible. So we will see, Shraddha. I mean, as the month of February closes and the month of March starts, we will see how that goes. But our job will be to try and mitigate as much as we can, if not all of them.
Right. Then secondly, in terms of service lines, if I see ERP decline by a sharp 6%, this is different from what other peers have been reporting in terms of opportunity in the SAP S/4HANA upgrade cycle. So is it something different, vis-à-vis competition that we've witnessed in this quarter? And how do you see this service line normalizing to growth trends from the next quarter?
Yeah. So, Shradha, look, again, if you look at the ERP business of ours, our ERP business is equally split between Oracle, SAP, and, of course, we have a JDE company as well. This service line, quite frankly, has not been doing well for the last two quarters. We have brought in more leadership to help this service line get back to growth. The S/4HANA story will first play out for the larger players. And even if you remember, in the last quarter, I had said the S/4HANA movement actually benefits the larger players to begin with, and eventually, it'll come down to the smaller players. I'm still very confident that the ERP business will turn around. And like I had said last quarter, it'll take us about two, three quarters more. But I remain confident we are invested in the business. We are getting more leadership in.
I don't know whether I will be able to turn it around in Q4 or Q1, but over the medium term, I can tell you, Shradha, this business will start growing.
Right. Then just last question, if I can. If I look at the revenue growth from the top 6 to 10 accounts, that has shown a sharp sequential decline of 5%. And on a YOY basis, it's down almost 14%-15%. So any client-specific concern to be called out in that client bucket?
Yeah. So some of this decline is because of the furloughs that I spoke about. So furloughs have impacted some of these clients, which was why they have shown a decline. I am not too worried from that standpoint because some of these revenues will come back. So if you measure us on a two- to three-quarter period when it comes to the top five accounts, you will see a normalized situation. But, Shradha, look, I am, and we as a management team are acutely aware that we need to do more in mining. We've had six quarters of great mining growth. Over the last three quarters, we've seen some amount of decline. So we are working with our clients, at least our top 10, top 15 clients, to see how we can get them back to growth.
So that's one of the things that we are sharply focused on as a management team.
Great. Thank you, and wish you all the best.
Thank you, Shradha.
Thank you. The next question is from Sandeep Shah from Equirus. Please go ahead.
Yeah. Hi. So, sir, the first question in the last earnings call clearly called out that the revenue pickup and the margin pickup will start from fourth quarter. And the margin pickup may continue over next four quarters of FY 2026 as well. And now we are also calling out 4Q may have some headwinds. So, sir, last two to three quarters, our predictability in terms of growth outlook, even for the immediate quarters, has been actually going down. So what are the reasons, according to you, Angan, and how are we looking to improve that this situation may not continue in FY 2026?
Yeah. So, Sandeep, great question. And let me be very candid and honest on this. See, as a management team, the two things that we ourselves are not very proud of is the fact that this year, the current financial year, whether it is Q1, Q2, Q3, or even Q4, our predictability has suffered, right? There are two reasons for that predictability issue. One is because our real estate, the clients that we serve, have been impacted slightly from their own performance standpoint. And we have had to get, for example, Q3, there have been verticals which came and told us about furloughs as late as the 10th of December, which we had never anticipated. I mean, in our history, we never got furloughs for them, but it happened this quarter.
So, in that kind of a scenario, it obviously becomes quite difficult to give certainty because we are not a very large business to be able to absorb all that furlough. So now let me tell you, Sandeep, what we are going to do to kind of make sure that going forward, this doesn't happen again. So two things we are doing. We are expanding our real estate in a significant manner. So some of the new local wins that we are working towards to get will obviously improve the situation. Second, we are also investing in our existing clients, our top 20, 25 clients, to make sure that we get the growth back. That is number two. Number three, the capabilities that we've invested in over so many quarters have actually not started yielding revenues. And at some point, Sandeep, they will start yielding revenues.
So, look, I mean, bottom line, next year, I feel with all the corrective actions that we have taken, our predictability will improve, right? I cannot comment in terms of how much growth will I deliver next year. It's hard to say. I'll probably be able to give you a complete view after Q4 is over, but I can only tell you the predictability will be far better next year. That is something that we are committing to us. On the margin improvement front, again, it's a matter of execution, correct? Now, we never knew that the furloughs will happen in January, and it is, Sandeep, very hard to predict that the furloughs would have happened, but I hope to mitigate some of the furloughs and still continue to work on our margin improvement, so that we will continue to do.
And if we can get the revenue back, then some of the margin issues will also go away. So these are the two or three things that we will do in terms of improving real estate, working with our existing accounts to get more certainty. And in the immediate Q4 quarter, trying to mitigate some of the furloughs and the rundowns to see how we can get the business back.
Okay. Angan, just to follow up, the impact of furloughs, which we have witnessed in Q3, would be also similar or higher in Q4? Because if it's similar, that means the incremental Q1, Q2 growth impact should not be that big.
Yeah. So I'm saying it will not be as much as Q3, obviously. It will be half of what we have witnessed in Q3. So to that effect, we have some cushion. But look, Sandeep, we've never witnessed furloughs in our business in Q4, let alone even in Q3 in, let's say, life sciences businesses. So it's a new world for us. But to answer your question, specifically, the amount of furloughs we saw in Q3 and the amount of furloughs we will see in Q4, the Q4 will be half as much as Q3.
Okay. Angan, if I look at the new business TCV for the first nine months, it is down on a YOY by 28%. So where are we going wrong? Because the order book with some of your peers has not given any major headwinds. They have actually shown a YOY improvement, even in some large-cap as well as mid-caps. So do you believe this is internal Birlasoft-related issue, or is it more to do with the demand with the set of customers which we serve?
Yeah. So look, Sandeep, last year, if you really think about it, there was one large deal that we had closed, if you remember. We closed a $100 million deal last year, correct? And that in actually the Q2, right? Q2. So that really swung our order book significantly last year. So if you were to take that one large deal out, okay, then if you compare the order book, then our order book has really grown. But that's no excuse, Sandeep. So even this year, we should close a—I mean, we obviously want to close a large deal. We've not closed any large deals this quarter. But if I look at between, let's say, January and, let's say, April, May, June, in the first six months of this calendar year, our attempt will be to close at least a couple of medium-sized deals, not large deals.
So things should start improving from there on. So that's answer number one. The answer number two, Sandeep, it is also a manifestation of the real estate that we hold, right? When our real estate companies, the companies that we serve, our top 20 accounts, though they are financially very stable, there's no problem financially. If their growth stutters a little bit, then we obviously have a problem, which is why I was telling Shraddha also that while the focus will be to grow our top 25 accounts, absolutely, and we will get them. We absolutely will get them back to growth. We have a plan to do that. We will also focus equally on creating new logos because our existing real estate, at some point in time, will plateau out, Sandeep.
Okay. And just last two, in terms of earlier call, which was post-2Q result, we had an aspiration to go to 15%-16% EBITDA by end of FY 2022. Is the growth outlook becoming slightly soft? And second question is in terms of the war chest, cash and bank balance as a percentage to market cap, if I'm not wrong, is as big as 14%-15% of the market cap. So are we looking to return this to shareholders, or we are in an active discussion in terms of M&A?
Yeah. So Sandeep, let me answer the first question, and then I will ask Kamini to also chime in on that, right? So actually, what was the first question?
The first question was in terms of our aspirations. So, Sandeep, let me take that question up, right? In terms of aspiration, if you remember last quarter, when we spoke about it, we said we expected our margins to bottom out in Q3, and then we'd slowly start inching upwards from a margin improvement standpoint. Our aspiration remains the same. That's where we want to get to. But I think the path to that could become a little slower given what we have seen from a Q4 standpoint, right? So I think I would say that from that standpoint. On your second question, given the cash that we are holding, do we have any plans as of now to return to the shareholders? I would say no at this point of time.
We may be looking at conserving cash for any potential opportunity that could come up in the future.
Yeah. And Sandeep, just to add, we have clearly mentioned that we will continue to improve our margins, right? So our goal is to absolutely do that, right? I mean, we have got a lot of internal processes that have got laid out now in terms of what will we do and how will we do to cut costs and cost takeout initiatives to improve the margins. But equally, Sandeep, we need to invest in our business, and we don't want to take a short-term measure because in the long term, I'm reasonably certain we'll get growth back. But to answer your question, we want to improve margins quarter over quarter. Q4, some furloughs have hit, and hopefully, we will not have any furloughs in Q1. So margins will see an improvement. On the cash front, we have continued to generate a lot of cash.
We will look at an M&A at some point in time, but right now, we want to deliver a couple of quarters of revenue growth. And as soon as we can deliver some quarters of revenue growth organically, then we will look at how we can look at an asset and if we can acquire an asset, etc. But right now, the entire management focus is operationally improving margins and delivering quarter on quarter revenue growth.
Yeah. And I'll just add to what you said, Angan. I think to Sandeep's question, we also consistently reward shareholders with the dividend payouts that we do. And despite being a slightly softer year, we've continued to do so. So to that extent, I think our philosophy on return back to shareholders has not changed, Sandeep.
Okay. Thanks. I will come in the follow-up. All the best.
Thank you.
Thank you. Next question is from Sudheer Guntupalli from Kotak Mutual Fund. Please go ahead.
Hey. Hi, Angan. Hi, Sandeep. Good evening. So just a couple of questions. Firstly, you are seeing a bit of an offshoring impact, and you had furloughs in December, and you expect only half of that furloughs in March quarter. And then despite the furloughs and some rundowns you called out, you are still sounding confident on FY 26 growth and your ability to mitigate the impact of it in Q4. So is this confidence coming from your, let's say, confidence that you'll be able to close that largely? Is that largely closing the bridge between the current quarter and FY 26 and your ability to mitigate in Q4?
Yeah. So Sudheer, let me correct that statement a little bit. Look, we have not said that we are confident of overcoming all the furloughs and the rundowns. Our best effort will be to try and mitigate most of it. How much will we be able to mitigate? How much will we not be able to mitigate? We don't know that yet. Okay? So that's number one. But of course, as a management team, all of our team's effort will be to mitigate maximum. So that is as far as the imminent Q4 is concerned. Now, again, when I talk about a reasonable size deal, and I will not call it a large deal, a reasonable size deal, considering our company's size, Sudheer, if we close that in this quarter, that revenues will start only flowing from Q1 and Q2.
So that gives us a little bit of more confidence for next year. But look, again, Sudheer, like I said, let me close Q4 first. And after we've closed Q4, I will be able to comment in terms of directionally how next year would look like. Though we never give a guidance, we will not give a guidance. But directionally, you will see, and we can comment in terms of how the next year would look like. Right now, our focus is to mitigate the furloughs and the rundowns in Q4.
Sure, Angan. And just on margins, right? I think the best time to reach high, you were able to maintain the margins stable quarter on a quarter basis, which is very impressive. So from here on, what are the headwinds that you have which you foresee at this stage, apart from the regular investments and, let's say, if the large deal materializes, that you'll have to do certain onsite investments and all? But apart from that, are there any other headwinds that you foresee at this stage? Because I think circling back to Sandeep's earlier question, Q3 possibly should be the peak of all the headwinds, including the wage hike. And despite that, you were able to sort of show better-than-expected margins.
Yeah. So Sudheer, let me answer the first part, and then I'll ask Kamini to add as well. So clearly, our endeavor is to keep improving the margins. But like Kamini also said, because in Q4, also, we are looking at furloughs, of course, the wage hike is not there, but the furloughs will still impact at least half of it, right? We need to see how we can execute through the quarter and see whether we can maintain margins or improve margins. Again, I am not giving a guidance here. I'm just telling you directionally that's where we want to go towards. And like I was telling Sandeep and Shraddha, our obviously endeavor will be to continue to improve margins going forward, right? Now, the other question, Sudheer, that you asked is in terms of what could be other possible impact on margins, right?
So the one possible impact is our business mix. If our infrastructure business continues to outperform our application business, then obviously, in the medium term, there could be margin impact. So that could be one. Second is the pricing pressures. Now, to date, we have not heard from the client asking for a discount. So that's a positive thing. But we don't know what happens in the future, so that we don't know. The third is, as we sign newer and newer deals, even if it's the medium size, the $13-$15 million deals, that is getting extremely competitive. So I don't know how much amount of pricing power we will have in those kind of deals. So I'm just giving you a broad direction in terms of where things are going. But look, from our perspective, we will be growth-focused.
We need to grow revenues for the company. And I will admit that FY 2025 has been a bad year for us. And FY 2026, we need to get the company back to growth. And I feel, with all the investments that we have done and all the optimization that our Chief Operating Officer is driving, margins at some point in time should also be back.
Sure, Angan. And maybe last one from my side. Possible to call out the furlough impact this quarter?
I can't give you exact numbers, Sudheer, because that is client-specific information. It will not be right to give numbers, but safe to assume it will be 50% of what we experience in Q3.
I meant in December, what was the QoQ growth that got shaved off because of furloughs? That was what I was asking.
Yeah. Sorry. Yeah, so I think, Sudheer, we really don't call out that very specifically, but I would say it would be at least about 150% in terms of what has got shaved off because of this.
Same here . Thanks , and all the reasons.
Thank you. The next question is from Dipesh Mehta from Emkay Global. Please go ahead.
Yeah. Thanks for the meeting. A couple of questions. First, about the quarter four, you indicated about two factors. One is furloughs, which is half of Q3, and second factor was rundown. Now, if I look, half of the weakness in Q4, it itself will give you positive growth in quarter four on QQ basis, plus rundown will negate it largely, so I just want to understand from a directional perspective whether we are seeing any improvement in business underlying growth momentum perspective. Considering last two, three quarters, we have taken some steps to accelerate revenue growth, investing in business capability as well as domain kind of things, so if you can provide some color around that. Second thing is about the demand, which also you are indicating some early signs of improvement, which is better than, let's say, two, three quarters back, which ideally should support growth improvement.
So if you can provide some perspective on that, that is question one. Second question is I just want to get sector-wise outlook because life sciences continue to remain weak for now, long period of time. Manufacturing end is also fairly weak. So if you can give some sense about four verticals where we are present, how we expect growth to play out in calendar 25 or some demand trend. Thank you.
Yeah. Thank you, Dipesh. So Dipesh, first of all, the demand situation for us has not changed too much. I only said that there are some green shoots of demand coming back in financial services. But that, again, is a very small part of our business, number one, Dipesh, and that is a little back-ended. So I don't see demand coming back for our industry and, frankly, for us as well in the next two quarters. It will probably happen in the back-ended for the calendar year. I'm not saying financial year, but calendar year. So that is number one. Number two, from our perspective, if you look at financial services, that has continued to show growth. That will continue to be strong. Of course, you may see one quarter here and one quarter there where financial services also could be flattish or slight amount of degrowth.
I can't comment on that. But overall, directionally, I think financial services is good for us. Healthcare, on the other side, has been hit by client-specific issues where, like I was telling the other members in the call, saying that there are customers of ours who are financially very strong, but they are facing headwinds in their own businesses and their revenue growth. That is in our healthcare. And that is simply affecting our performance as well. I strongly believe that our healthcare business will come back to growth. I understand that it's been four quarters of not good performance. And we've done two things, Dipesh. One is we've hired a very senior leader to run our med devices business. As you know, almost 70% of our business is med devices.
We've hired a leader from a tier-one company who's just joined us to lead our med devices under the healthcare vertical. We are also in the process of hiring another leader to run our balance part of the business, which is the pharma business, again, under the healthcare vertical leader. We're strengthening that team. With some of these investments that we are doing, I'm hoping that that business will turn around. Now, coming specifically to Q4, Dipesh, look, like I keep saying, while we are looking at those headwinds, our job is to execute for the quarter. We will try our best to minimize the impact of furloughs and the rundowns. How much we will do, I can't comment right now. We will wait and see. That's our commitment.
From an underlying business resilience perspective, I have said that Q3 and Q4 will be good in terms of order booking. We've delivered strong order booking Q3. We hope to deliver strong order booking Q4 also. And that is giving us a slight amount of confidence that FY 2026 will hopefully be a better year. But let Q4 finish, and then we'll give a directional commentary in terms of how FY 2026 looks like.
No, Angan, I think two things left. I think manufacturing and E&U, I think you have not covered. And second thing is about deal interest. When you said good, do you think current level of order book is sufficient for you to return to double-digit growth rate?
No, I don't think so. So, Dipesh, quite frankly, the current level of order book is not sufficient for us to deliver double-digit growth, right? But is it good enough for us to get back to sequential growth? It is, right? So, Dipesh, look, I mean, let's waterfall that over. Then I will give you directionally in terms of how FY 26 would look like.
Maybe if you can give us a bit about the other two verticals, how you are seeing demand trends in them.
Yeah. E&E, I think we'll pick up. E&E also, because we have got a couple of deals that are currently going on, that may not close in Q4, but will definitely close in Q1. So from that perspective, I think E&E will be back. Manufacturing will be soft for another couple of quarters. So if you look at the larger picture, I think E&E and financial services will lead growth over the next one year. Now, again, one quarter, you may see financial services also impacted. But I think over the next four quarters, if you normalize, financial services and E&E will continue to grow. Manufacturing will take a couple of quarters to come back. Healthcare also. I'm reasonably confident that in a couple of quarters, it will come back.
Thank you.
Thank you. A reminder to participants that you may press star and one to ask questions. Ladies and gentlemen, to ask a question at this time, you may press star and one. Well, as there are no further questions, I would like to hand the conference over to Mr. Angan Guha, CEO and MD of Birlasoft Limited, for closing comments.
Yeah. Thank you, everyone. Thank you for attending the conference call. And I truly appreciate your interest in Birlasoft. As I said, the quarter that went by was a tough quarter for us in terms of revenue as well as in terms of the furlough impact that we saw. But the positives in our performance have been our order book. Order book was strong. And the ability to maintain margins in a quarter where we gave a wage hike and had the furlough impact, I think, was positive. Me and my team will be focused on getting the predictability back. We understand the predictability has been a big issue. So our big focus will be to get the predictability back as we try and close more deals to enable to deliver better sequential growth quarters. So thank you once again.
And I hope to speak to all of you at the end of Q4. Thank you.
Thank you very much. On behalf of Birlasoft, that concludes this conference. Thank you for joining us, ladies and gentlemen. You may now disconnect your lines.